Merck & Co. Inc. buy BiotechBee
Start price
08.11.22
/
70%
€100.60
Target price
31.01.25
€150.00
Performance (%)
5.77%
End price
05.05.23
€106.40
Summary
This prediction ended on 05.05.23 with a price of €106.40. The BUY prediction by BiotechBee finished with a performance of 5.77%. A total of €0.68 was paid as dividends for this prediction. BiotechBee has 70% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Merck & Co. Inc. | 2.024% | 2.024% | 15.458% |
iShares Core DAX® | -1.370% | -3.231% | 11.661% |
iShares Nasdaq 100 | 0.172% | -3.339% | 36.491% |
iShares Nikkei 225® | -0.801% | -7.859% | 18.597% |
iShares S&P 500 | -0.369% | -2.979% | 26.341% |
According to BiotechBee what are the pros and cons of Merck & Co. Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by BiotechBee for this prediction
In the thread Merck & Co. Inc. diskutieren
Buy mit Kursziel 150,0
In the thread Trading Merck & Co. Inc.
Buy beendet